Ftse Mib
34.447,61
-1,08%
DAX
18.686,62
-0,43%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
71.142,70
-0,43%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pieris Pharmaceuticals Inc (PIRS) Pieris Pharmaceuticals Inc (PIRS) Notizie

PIRS

Pieris Pharmaceuticals (PIRS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PIRS
DataOraFonteTitoloSimboloCompagnia
15/05/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
09/05/202414:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202422:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
31/08/202322:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
10/08/202323:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PIRSPieris Pharmaceuticals Inc
26/06/202323:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
23/06/202322:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/06/202312:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PIRSPieris Pharmaceuticals Inc
22/05/202323:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PIRSPieris Pharmaceuticals Inc
11/05/202312:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202322:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202322:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
31/03/202322:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202322:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
03/01/202322:56Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/11/202222:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/08/202223:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/05/202212:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
29/04/202222:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/01/202215:15TipRanksAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pieris Pharmaceuticals (PIRS) and Biohaven Pharmaceutical Holding Co (BHVN)NASDAQ:PIRSPieris Pharmaceuticals Inc
16/08/202112:36Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PIRSPieris Pharmaceuticals Inc
05/08/202122:49Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202112:18TipRanksWhat Makes Penny Stock Pieris Pharma A “Strong Buy”?NASDAQ:PIRSPieris Pharmaceuticals Inc
01/06/202122:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PIRSPieris Pharmaceuticals Inc
27/05/202100:37TipRanksPieris: Shares Can Still Soar Much Higher, Says AnalystNASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202023:00Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
20/11/201914:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/11/201814:00GlobeNewswire Inc.Pieris Pharmaceuticals to Present at Investor Conferences in NovemberNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/201813:00GlobeNewswire Inc.Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:PIRSPieris Pharmaceuticals Inc
31/10/201813:00GlobeNewswire Inc.Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018NASDAQ:PIRSPieris Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PIRS

La tua Cronologia

COIN
EVILBTC
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network